Pharmaceutical Quality System Module 2

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/50

flashcard set

Earn XP

Description and Tags

Vocabulary terms and definitions related to Quality Risk Management, Contamination, Cross-Contamination, Good Documentation Practice, Good Laboratory Practice, and Self-Inspection from Module 2 of the Pharmaceutical Quality System course.

Last updated 10:18 AM on 7/25/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

51 Terms

1
New cards

Quality Risk Management

A systematic process for the assessment, control, communication and review of risks to the quality of the drug (medicinal) product across the product lifecycle.

2
New cards

Decision Maker(s)

Person(s) with the competence and authority to make appropriate and timely quality risk management decisions.

3
New cards

Detectability

The ability to discover or determine the existence, presence, or fact of a hazard.

4
New cards

Harm

Damage to health, including the damage that can occur from loss of product quality or availability.

5
New cards

Hazard

The potential source of harm.

6
New cards

Product Lifecycle

All phases in the life of the product from the initial development through marketing until the product’s discontinuation.

7
New cards

Quality

The degree to which a set of inherent properties of a product, system or process fulfills requirements.

8
New cards

Quality System

The sum of all aspects of a system that implements quality policy.

9
New cards

Requirements

The explicit or implicit needs or expectations of the patients.

10
New cards

Risk

The combination of the probability of occurrence of harm and the severity of that harm.

11
New cards

Risk Acceptance

The decision to accept risk.

12
New cards

Risk Analysis

The estimation of the risk associated with the identified hazards.

13
New cards

Risk Assessment

A systematic process of organizing information to support a risk decision to be made within a risk management process.

14
New cards

Risk Communication

The sharing of information about risk and risk management between the decision maker and other stakeholders.

15
New cards

Risk Control

Actions implementing risk management decisions (ISO Guide 73).

16
New cards

Risk Evaluation

The comparison of the estimated risk to given risk criteria using a quantitative or qualitative scale to determine the significance of the risk.

17
New cards

Risk Identification

The systematic use of information to identify potential sources of harm.

18
New cards

Risk Management

The systematic application of quality management policies, procedures, and practices to the tasks of assessing, controlling, communicating and reviewing risk.

19
New cards

Risk Reduction

Actions taken to lessen the probability of occurrence of harm and the severity of that harm.

20
New cards

Risk Review

Review or monitoring of output/results of the risk management process considering (if appropriate) new knowledge and experience about the risk.

21
New cards

Severity

A measure of the possible consequences of a hazard.

22
New cards

Stakeholder

Any individual, group or organization that can affect, be affected by, or perceive itself to be affected by a risk.

23
New cards

Trend

A statistical term referring to the direction or rate of change of a variable(s).

24
New cards

PDCA Cycle

A powerful tool used in manufacturing to help organizations achieve continuous improvement, standing for Plan, Do, Check, Act.

25
New cards

High Risk

Indicates a severe, unacceptable threat to patient health, where immediate corrective and preventive actions are mandatory.

26
New cards

Medium Risk

Threatens process stability or product quality but does not pose an immediate danger; requires mitigation and documented reduction strategies.

27
New cards

Low Risk

Minor or remote deviations that are often acceptable with standard operating procedures without extensive additional measures.

28
New cards

RPN

The Risk Priority Number, established by the formula RPN=S×O×DRPN = S \times O \times D, where S is Severity, O is Occurrence, and D is Detectability.

29
New cards

Failure Mode Effects Analysis (FMEA)

Provides for an evaluation of potential failure modes for processes and their likely effect on outcomes and/or product performance.

30
New cards

Failure Mode, Effects and Criticality Analysis (FMECA)

Identifies places where additional preventive actions might be appropriate to minimize risks.

31
New cards

Fault Tree Analysis (FTA)

A tool that evaluates system or sub-system failures one at a time, combining multiple causes by identifying causal chains.

32
New cards

Hazard Analysis and Critical Control Points (HACCP)

A systematic, proactive, and preventive tool for assuring product quality, reliability, and safety.

33
New cards

Hazard Operability Analysis (HAZOP)

A theory assuming that risk events are caused by deviations from the design or operating intentions.

34
New cards

Preliminary Hazard Analysis (PHA)

An analysis tool based on applying prior experience or knowledge of a hazard or failure to identify future hazards that might cause harm.

35
New cards

Pharmaceutical Contamination

The unintended presence of foreign substances in a drug product that may adversely affect its quality, safety, and therapeutic effectiveness.

36
New cards

Physical Contamination

Occurs when unwanted foreign objects or particles such as glass fragments, metal particles, dust, or fibers are present.

37
New cards

Chemical Contamination

The accidental introduction of chemicals like residual solvents, cleaning agents, or lubricants.

38
New cards

Microbial Contamination

Occurs when microorganisms such as bacteria, fungi, viruses, or their by-products are present in a product.

39
New cards

Endotoxin/Pyrogen Contamination

The presence of substances, such as lipopolysaccharide (LPS) from Gram-negative bacteria, that can cause fever and harmful immune reactions.

40
New cards

Cross-contamination

The unintended transfer of traces of one product, material, or substance to another during the manufacturing process.

41
New cards

Good Documentation Practice (GDP)

A systematic procedure of preparing, reviewing, approving, issuing, recording, storing and archiving of documents.

42
New cards

Raw Data

Any worksheets, records, memoranda and notes of original and first-hand observations and activities of a study necessary for reconstruction and evaluation.

43
New cards

ALCOA

A technique to ensure data compliance standing for Attributable, Legible, Contemporaneous, Original, and Accurate.

44
New cards

Attributable

Requirement that all data must be traceable to the person generating it, including who performed the action and when.

45
New cards

Legible

Requirement that all paper and electronic data must be readable and permanent.

46
New cards

Contemporaneous

The practice of recording paper or electronic data at the time it is performed.

47
New cards

Original

The paper or electronic medium in which the data point is initially recorded, such as protocols, notebooks, or software.

48
New cards

Accurate

Requirement that data should be free from errors, complete, truthful, and reflective of the observation.

49
New cards

Batch Processing Records

A part of the Batch Manufacturing Record kept for each batch to avoid transcription errors and provide evidence of processing actions.

50
New cards

Good Laboratory Practice (GLP)

A quality system concerned with the organizational process and conditions under which non-clinical health and environmental safety studies are conducted.

51
New cards

Self-Inspection

Conducted to monitor the implementation and compliance with Good Manufacturing Practice (GMP) principles and propose corrective measures.